ClinicalTrials.gg
Not yet recruitingNCT07568106Updated May 5, 2026

Adductor Canal Block With or Without Biceps Femoris Short Head Block in Total Knee Arthroplasty

An interventional study of Adductor Canal Block and Biceps Femoris Short Head Block in Total Knee Arthroplasty, sponsored by Cukurova University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-05-05.

Sponsored by Cukurova University · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
132
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 33 studies in Pain, Postoperative by Cukurova University — 4 open to participants now, 4 under way, none of them phase 3. Pain, Postoperative · Cukurova University.

Planned enrollment
3rd of 33
132 · median 60
Started
2026
with 1 other
No phase
20 of 33
4 open now
Registered
32nd of 33
by date

Among the 33 studies in Pain, Postoperative by Cukurova University, this one is the 3rd largest by planned enrollment, is one of 2 that started in 2026, is one of 20 with no phase, and was the 32nd registered.

Pain, Postoperative

5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.

Browse Pain, Postoperative studies →

Open to participants now

4 of the 33 studies in Pain, Postoperative by Cukurova University are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 4 open studies →

Where they have run

Who these studies take

Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.

This study: 18 Years to 80 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 33 studies in Pain, Postoperative by Cukurova University, or all of them as a file.
02

Study summary

Total knee arthroplasty is associated with moderate to severe postoperative pain, which may delay mobilization and recovery. Multimodal analgesia including regional anesthesia techniques is widely used to improve outcomes. The adductor canal block (ACB) provides anteromedial knee analgesia but may not adequately cover the posterolateral region.

The biceps femoris short head (BiFeS) block is a novel motor-sparing regional anesthesia technique targeting the posterolateral capsule of the knee. This randomized controlled trial aims to compare the analgesic efficacy and functional outcomes of ACB combined with BiFeS block versus ACB alone in patients undergoing total knee arthroplasty.

The primary outcome is posterior knee pain at postoperative 6 hours. Secondary outcomes include pain scores within 48 hours, opioid consumption, early and late functional recovery, and opioid-related adverse effects.

03

Conditions studied

  • Total Knee Arthroplasty

Keywords

  • Total Knee Arthroplasty
  • Adductor Canal Block
  • Biceps Femoris Short Head Block
  • Postoperative Pain
  • Functional Recovery
  • Opioid Consumption
  • Knee Osteoarthritis
04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult patients undergoing unilateral primary TKA
  • Planned spinal anesthesia
  • Written

Exclusion criteria

Exclusion Criteria:

  • Coagulopathy
  • Drug allergy
  • > 35
  • Renal/hepatic failure
  • Chronic pain or opioid use
  • Depression or psychiatric disorder
  • Revision or bilateral TKA
  • Neurological deficits
  • Preoperative ROM \< 90°
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
132 participants (estimated)

Study arms

  • Experimental
    ACB + BiFeS

    Participants receive spinal anesthesia followed by an ultrasound-guided adductor canal block and a biceps femoris short head block using local anesthetic for postoperative analgesia.

    Procedure: Adductor Canal Block · Procedure: Biceps Femoris Short Head Block

  • Active comparator
    ACB + sham BiFeS

    Participants receive spinal anesthesia followed by an ultrasound-guided adductor canal block and a sham biceps femoris short head block using normal saline.

    Procedure: Adductor Canal Block · Procedure: Sham Biceps Femoris Short Head Block

Interventions

  • ProcedureAdductor Canal Block

    Ultrasound-guided adductor canal block performed with injection of local anesthetic into the adductor canal to block the saphenous nerve and provide postoperative analgesia following total knee arthroplasty.

  • ProcedureBiceps Femoris Short Head Block

    Ultrasound-guided biceps femoris short head block performed with injection of local anesthetic between the biceps femoris short head and femur to target the posterolateral innervation of the knee for postoperative analgesia.

  • ProcedureSham Biceps Femoris Short Head Block

    Sham ultrasound-guided biceps femoris short head block performed with injection of normal saline at the same anatomical location to maintain blinding without providing active analgesia.

06

What researchers measure

Primary outcomes

  1. Posterior Knee Pain Intensity

    Posterior knee pain assessed using the Numeric Rating Scale (NRS, 0-10), where 0 indicates no pain and 10 indicates worst imaginable pain.

    Time frame: 6 hours postoperatively

Secondary outcomes

  1. Postoperative Pain Intensity

    Pain intensity at rest and during movement assessed using the Numeric Rating Scale (NRS, 0-10).

    Time frame: 30 minutes, 1, 6, 12, 24, and 48 hours postoperatively

  2. Total Opioid Consumption

    Total opioid consumption measured from patient-controlled analgesia (PCA) device and additional opioid requirements, expressed in milligrams of morphine equivalent.

    Time frame: 0-48 hours postoperatively

  3. Rescue Analgesic Use

    Requirement for additional analgesic medications (e.g., meperidine, paracetamol, ibuprofen) recorded as yes/no and total doses administered.

    Time frame: 0-48 hours postoperatively

  4. Functional Recovery

    Functional recovery assessed by range of motion (ROM), quadriceps muscle strength, time to first ambulation, ability to walk 10 meters without assistance, and performance on the 5-times sit-to-stand test.

    Time frame: 24 hours, 48 hours, and 6 weeks postoperatively

  5. Quadriceps Muscle Strength

    Quadriceps isometric muscle strength measured using a handheld dynamometer and expressed in Nm/kg.

    Time frame: Preoperatively, 24 hours, 48 hours, and 6 weeks postoperatively

  6. Time to First Ambulation

    Time from the end of surgery to first successful ambulation, measured in hours.

    Time frame: Within 48 hours postoperatively

  7. Patient Satisfaction

    Patient satisfaction with postoperative pain management assessed using a 4-point scale (excellent, good, moderate, poor).

    Time frame: 48 hours postoperatively

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for May 2026; primary completion for Jan 2027, 8 months later.

Of 2,113 non-industry interventional studies with no phase under Pain, Postoperative, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's planned 8 months is below that.

Counting every sponsor, half of 2,126 studies reached it within 11 months; a quarter within 6 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 23, 2026
First posted
May 5, 2026
StartEst.
May 15, 2026
Primary completionEst.
Jan 15, 2027
CompletionEst.
Feb 15, 2027
Last update
May 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 5, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07568106
Responsible party
Demet Laflı Tunay (Associate Professor of Anesthesiology, Cukurova University) — Principal investigator
First posted
May 5, 2026
Start date
May 15, 2026 (estimated)
Primary completion
Jan 15, 2027 (estimated)
Completion
Feb 15, 2027 (estimated)
Last update
May 5, 2026

Study contacts

Demet Lafli Tunay, M.D.
Contact
dlafli@yahoo.com
+905358685831

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion